PhRMA Throws Support Behind Opioid Prescribing Limits, Mandatory Education

Drug industry lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) on Monday (Dec. 11) threw its support behind a number of policy proposals to tackle the opioid crisis, including limits on prescribing, a ban on prescribing of Schedule II opioids in an office setting, ongoing prescriber training, expanded access to addiction treatment options, and development of abuse-deterrent formulations (ADFs) of opioids. The group released its policy proposals in conjunction with the announcement that PhRMA and the Addiction Policy Forum...